When developing cannabis and hemp products, few compounds impact a formulation’s effects and sensory profile as significantly as β-myrcene. As the most abundant terpene in cannabis, myrcene forms the foundation of countless successful product formulations—from premium vape cartridges to therapeutic topicals.
This technical guide provides product developers, formulators, and manufacturers with evidence-based insights on myrcene’s properties, optimal usage rates, and formulation considerations that directly impact product performance and consumer experience.
The data and recommendations are drawn from Terpene Belt Farms’ extensive extraction experience and peer-reviewed research on cannabis terpenes.
Key Takeaways
- Representing over 32% of total terpene content on average, β-myrcene plays a central role in defining the sensory profile and therapeutic effects of cannabis products.
- Myrcene’s low boiling point and sensitivity to air, heat, and light make it hard to work with, necessitating careful formulation strategies to prevent degradation, especially in vapes, tinctures, and topicals.
- Peer-reviewed studies support myrcene’s sedative, analgesic, anti-inflammatory, and muscle-relaxant effects, particularly when combined with cannabinoids.
- Effective concentrations differ across product formats and formulations, with cannabis-derived myrcene consistently outperforming botanical versions due to its broader terpene synergy.
What Is Myrcene? Chemical Properties and Identification
Myrcene (β-myrcene or 7-methyl-3-methylene-1,6-octadiene) is a monoterpene hydrocarbon with the molecular formula C₁₀H₁₆. This compound features an earthy, musky aroma with subtle notes of clove and fruit that become more pronounced at higher concentrations.
Research identifies myrcene as one of the primary contributors to cannabis aroma, with detection thresholds as low as 14 parts per billion in certain sensory environments.
From a formulation standpoint, myrcene presents properties that impact product stability and performance. Its boiling point of 166-168°C (331-334°F) makes it particularly volatile during vaporization, requiring specific handling in thermal applications. With a density of 0.794 g/cm³ at 20°C, myrcene is lighter than water and tends to separate in aqueous solutions without proper emulsification.
When working with cannabis terpene extracts, formulators must account for myrcene’s high solubility in alcohols and oils but poor water solubility. We experience significant stability challenges when myrcene-rich extracts are exposed to air, heat, or light, accelerating oxidation and leading to off-notes in finished products.
In cannabis analytics, myrcene is typically identified through gas chromatography-mass spectrometry (GC-MS) or high-performance liquid chromatography (HPLC) testing. When reviewing Certificates of Analysis (COAs), formulators should look for myrcene content expressed as mg/g or percentage by weight, with cannabis-derived samples ranging from 0.27% to over 2% in high-myrcene cultivars.
Our Terpene Belt Farms quality testing protocols include detailed terpene profiling to ensure consistent myrcene content in all product batches.
Myrcene Concentration in Cannabis Strains: Understanding Terpene Profiles
Myrcene concentrations vary widely across cannabis cultivars due to genetics, cultivation practices, harvest timing, and environmental factors. While consumer-facing websites often make sweeping generalizations about indica vs. sativa myrcene content, the reality is more nuanced.
A study that analyzed 11 cannabis varieties found that myrcene concentration typically ranges from 0.04% to 1.89%, with no clear correlation to the indica/sativa classification widely used in marketing.
This concentration data aligns with a 2011 study that analyzed 30 commercial cannabis varieties and found myrcene concentrations of up to 46.1±2.6% in certain phenotypes. Our premium terpene profiles accurately preserve these naturally occurring concentrations.
Based on our extensive terpene profiling database, here are typical myrcene ranges in various cannabis strain categories:
High-Myrcene Cannabis Strains (>0.5% by weight)
- OG Kush lineage: 0.58-1.68% Blue Dream: 0.45-1.23% Granddaddy Purple: 0.54-1.05%
- The Sweet #16 and Sweet#161 profiles are perfect for formulators seeking high concentrations of myrcene and feature a rich blend of lavender, butterscotch, and mint chocolate chip notes, reminiscent of the Juicy Fruit strain.
- Gas#707 is another myrcene-rich, bold profile featuring tart cherry and lemongrass notes, akin to the ATF strain.
Moderate-Myrcene Cannabis Strains (0.2-0.5% by weight)
- Sour Diesel: 0.17-0.47% Cherry Pie: 0.22-0.38%
- The Sour #92, Fruit #132, and Purple #101 are a few of our many terpene profiles with moderate myrcene concentrations.
Other profiles with moderate-to-high myrcene concentrations worth checking out include:
- Purple #100: Evokes grape and wild cherry flavors, similar to Granddaddy Purple and Grape Ape strains.
- Sweet #62: Offers a sweet and spicy aroma with ylang ylang and sarsaparilla notes, reminiscent of the Sherbert strain.
- Fruit #505: Combines Kahlua and orchard fruit notes, echoing the LA Confidential strain.
- Pine #606: Delivers a savory profile with mocha and key lime, similar to the Dutch Treat strain.
- Sweet #602: A vibrant blend with limeade and tropical fruit notes, reminiscent of the Papaya Punch strain.
- Sweet #710: Features citrus and berry flavors, akin to the Pineapple Express strain.
- Gas #151: Presents a complex profile with terpinolene and limonene, similar to the Citron strain.
- Fruit #132: Offers dessert-inspired flavors like lavender lemonade and meringue pie, reminiscent of Cherry Bomb and Skittlez strain.
Low-Myrcene Cannabis Strains (<0.2% by weight)
- Tangie: 0.05-0.17%, Strawberry Cough: 0.08-0.19%.
Understanding these concentration ranges is critical when developing products for specific effects. For sedating formulations, optimal results are achievable with terpene profiles containing myrcene at the higher end of the range.
This is supported by research suggesting that myrcene concentrations above 0.5% contribute significantly to sedative effects when combined with cannabinoids.
We have documented significant variance in myrcene expression based on microclimates within California’s growing regions. Notably, plants from the coastal areas typically express 8-12% higher myrcene concentrations than inland cultivars of identical genetics.
This terroir factor is critical when sourcing cannabis-derived terpenes for consistent product development. These findings are incorporated into our cultivation practices to maximize desirable terpene expression.
Myrcene Effects: Scientific Research and Formulation Implications
Product developers need an evidence-based understanding of myrcene’s properties to create effective formulations that deliver consistent results. Here is what peer-reviewed research says about myrcene’s pharmacological profile:
Sedative Properties
Myrcene exhibits significant sedative effects, with studies showing dose-dependent sedation at concentrations of 200 mg/kg in rodent models, potentiating barbiturate sleeping time by nearly 2.6 times (157% increase, p<0.001).
For product developers, this research suggests myrcene-dominant formulations are best suited for nighttime or relaxation-focused products. From our experience, products containing >0.5% myrcene typically induce relaxation, with more pronounced sedative effects at concentrations >0.8%. This is relevant when creating vape formulations for relaxation.
Analgesic Effects and THC Synergy
Myrcene exhibits direct and indirect analgesic properties due to its ability to potentially reduce inflammatory pain through interaction with α2 adrenergic receptors. These analgesic properties can enhance the overall effectiveness of topical cannabis products.
There is also evidence that combining myrcene with cannabinoids produces stronger pain-relieving effects than isolated cannabinoids at equivalent doses. This is largely theorized as the entourage effect.
When formulating pain-targeted products, optimal results are achieved with myrcene-to-THC ratios between 1:20 and 1:10, depending on delivery method and target effect intensity.
Muscle Relaxant Properties
Multiple studies confirm myrcene’s muscle-relaxant effects. For topical formulations targeting muscle tension, we have found that myrcene concentrations of 0.2-0.5% yield optimal muscle-relaxant effects without overwhelming the sensory profile.
Anti-Inflammatory Activity
Lorenzetti et al. (1991) found that myrcene inhibits prostaglandin E2 production, thus demonstrating potential anti-inflammatory activity. Our cannabis flower enhancement products leverage these properties for improved therapeutic potential.
These research-backed properties make myrcene valuable in formulations targeting stress relief, sleep support, and pain management. However, effect intensity depends heavily on using authentic cannabis-derived terpenes rather than synthetic or botanical alternatives, which typically lack the complete spectrum of synergistic compounds present in native extracts.
Myrcene in Product Development: Optimal Concentrations and Formulation Guidelines
Successful integration of myrcene into commercial products requires a precise understanding of appropriate concentration ranges for different product categories. Based on our formulation experience and stability testing data, we recommend the following guidelines:
Vape Cartridges and Concentrates
Optimal concentration range: 0.5-2.0% w/w
Our tests indicate formulators should monitor viscosity changes when myrcene concentrations exceed 1.5% to avoid affecting hardware performance in certain cartridge designs.
When developing vape products, 15-22% of myrcene is lost during vaporization at typical cartridge temperatures (180-220°C). Stability data from accelerated aging tests shows that formulations stabilized with 0.1-0.2% tocopherol derivatives exhibit 35% less oxidation over six months compared to unstabilized controls.
Based on our internal stability tests, blending myrcene with sesquiterpenes like β-caryophyllene and α-humulene at a 2:1 ratio reduces evaporation loss by up to 18% during storage.
Tinctures and Oral Oils
Optimal concentration range: 0.2-0.8% w/w
Research shows that lipid-based delivery systems significantly enhance terpene bioavailability compared to alcohol-based carriers. For optimal stability, use MCT or other carrier oils with low peroxide values (<2.0) to prevent myrcene degradation.
We recommend nitrogen-flushing headspace to extend shelf stability beyond 12 months, as oxidation studies show reduced degradation under inert gas conditions. When working with terpene-infused products, formulators should consider acid-catalyzed cyclization of myrcene at pH <4.0 when developing citrus-flavored formulations.
Topicals and Transdermals
Optimal concentration range: 0.3-1.2% w/w
There is evidence that monoterpenes like myrcene can enhance skin penetration of active ingredients by temporarily disrupting the stratum corneum’s lipid organization. Our in-house tests confirm that myrcene’s transdermal absorption rate is higher than that of other common monoterpenes.
For optimal formulation stability, incorporating 0.05-0.1% rosemary extract in the oil phase extends shelf life by reducing oxidation markers by up to 28% in accelerated stability testing. These findings inform our approach to terpene preservation in finished products.
Edibles and Beverages
Optimal concentration range: 0.01-0.08% w/w (edibles), 5-20 ppm (beverages)
According to research, microencapsulation techniques can produce higher retention of essential oils than direct addition methods. Pre-solubilizing in ethanol or using nanoemulsion technology (50-150nm particle size) improves homogeneity and sensory consistency when formulating terpene-infused beverages.
Our tests consistently show that cannabis-derived myrcene exhibits 15-25% stronger physiological effects than botanical myrcene at identical concentrations, as measured through in vitro receptor binding assays. This performance difference likely results from complementary compounds in full-spectrum extracts that are absent in isolated botanical sources.
Cannabis-Derived vs. Botanical Myrcene: Critical Differences for Product Developers
While myrcene is found in various sources, there are significant performance differences between cannabis-derived terpenes (CDT) and botanical alternatives. Understanding these distinctions helps product developers make informed sourcing decisions based on technical requirements rather than cost considerations only.
Chemical Profile Comparison
Research shows that cannabis-derived myrcene differs from botanical sources (primarily hops and mangos) in several key aspects:
| Characteristic | Cannabis-Derived Myrcene | Botanical Myrcene | Synthetic Myrcene |
| Isomer ratio | Higher β-myrcene content (>92%) | Variable isomer distribution (76-89% β-myrcene) | Almost entirely β-myrcene (>97%) |
| Companion compounds | Contains trace cannabinoids and synergistic terpenes | Contains plant-specific compounds | Lacks complementary compounds |
| Aroma profile | Complex, earthy with herbal undertones | Simpler, hop-like, or fruity notes | One-dimensional, chemical undertones |
| Effect intensity | Stronger sedative and analgesic effects at equal concentrations | Moderate effects requiring higher dosing | Inconsistent effects despite chemical purity |
| Oxidation resistance | Moderate natural stability | Variable, often requiring additional antioxidants | Poor, prone to rapid degradation |
Our extraction processes preserve the natural terpene profile of Cannabis Sativa L, including the precise isomer ratios and minor compounds that contribute to the entourage effect.
GC-MS analyses of our products typically show 20-35 detectable terpene compounds in cannabis-derived myrcene profiles, compared to just 5-10 compounds in botanical alternatives from non-cannabis sources. This significant difference affects both sensory and physiological effects.
Performance Implications in Commercial Products
Naturally, the source of terpenes significantly impacts overall product performance. Our tests also confirm this across several parameters, such as:
Sensory authenticity: Cannabis-derived myrcene delivers the authentic cannabis aroma profile consumers expect, which is particularly important for vape products and concentrates where terpene aroma directly influences perceived quality.
Indeed, blind testing shows consumers can distinguish cannabis-derived terpenes from botanical alternatives based on aroma complexity alone.
Effect consistency: Products formulated with cannabis-derived myrcene exhibit predictable effects across consumer testing panels. Our internal tests show variations in reported relaxation effects when using cannabis-derived myrcene over botanically-derived alternatives at identical concentrations. This consistency is critical when developing branded cannabis products with reliable consumer experiences.
Oxidative stability: Accelerated stability tests in our labs suggest cannabis-derived myrcene retains more potency after 12 months when properly stored, compared to isolated botanical myrcene under identical conditions.
Formulation compatibility: When developing cannabis concentrates, cannabis-derived myrcene demonstrates superior compatibility with cannabinoids, reducing phase separation issues and improving homogenization in complex matrices based on viscosity and stability measurements.
For premium product developers, these performance advantages often justify the higher investment in cannabis-derived terpenes, particularly for flagship products where consistency and effect reliability directly impact consumer loyalty and brand reputation.
Further recommendations:
- Temperature: -8°C (35-46°F) for bulk terpenes; 15-21°C (59-70°F) for finished products
- Light exposure: Use amber glass or opaque containers to prevent photodegradation
- Oxygen contact: Nitrogen-flush containers and minimize headspace in storage vessels
- Packaging materials: Use only borosilicate glass, high-density polyethylene, or fluorinated plastics (avoid polystyrene and PVC)
Stability Monitoring
We recommend the following quality control procedures for myrcene-containing products:
- Conduct accelerated stability testing at 40°C/75% RH to predict shelf life
- Monitor peroxide value (should remain <10 meq/kg) as an indicator of terpene oxidation
- Implement regular sensory evaluation protocols to detect early signs of myrcene degradation (development of harsh, chemical notes)
- Establish retest protocols at 3, 6, and 9 months for products containing >0.5% myrcene
Using these technical controls ensures myrcene-containing formulations maintain their intended effect profile and sensory characteristics throughout their commercial lifecycle.
Practical Applications: Myrcene in Commercial Cannabis Products
Product developers can leverage myrcene’s beneficial properties to achieve specific consumer experiences.
Sleep-Supporting Vape Formulations
Terpene-cannabinoid combinations show significant promise for sleep improvement. For vape products targeting improved sleep quality, myrcene concentrations of 0.8-1.2% produce optimal results when combined with linalool (0.3-0.5%) and appropriate cannabinoid ratios.
When developing sleep-focused products, we ensure our Fresh Never Frozen® terpene extraction method preserves the volatile compounds contributing to these sedative effects. Brands specifically looking for sleep-supportive profiles should consider our Pine terpene profiles, which naturally contain optimal myrcene concentrations.
Anti-Inflammatory Topicals
Research suggests that combining myrcene with β-caryophyllene produces enhanced anti-inflammatory effects through complementary mechanisms. Topical formulations containing 0.6-1.0% myrcene and β-caryophyllene at similar concentrations produce stronger relief in consumer tests.
Our formulations indicate that the optimal carrier base for such applications should contain moderate amounts (10-15%) of dimethyl isosorbide or propylene glycol to improve terpene penetration through the stratum corneum. Based on diffusion cell testing, this increases measured transdermal delivery by roughly 35%.
For manufacturers of topical cannabis products, our Native Cannabis Terpenes offer superior performance compared to botanical alternatives. Tests show higher anti-inflammatory activity (in vitro) in cell-based assays using our cannabis-derived extracts versus isolated botanical terpenes.
Strain-Specific Terpene Restoration
Accurate myrcene proportions are critical for strain authenticity when restoring terpene profiles to distillate-based products.
Based on this, our distillate formulation guide provides precise ratios for authentic strain recreation. For instance, manufacturers seeking to restore authentic OG Kush profiles should target myrcene concentrations of 0.7-1.1%, depending on desired intensity. Sour Diesel reconstructions typically require 0.3-0.5% myrcene balanced with higher limonene content.
For manufacturers working with distillate and isolated cannabinoids, selecting the appropriate myrcene concentration and strain-specific terpene ratio improves product authenticity and effect consistency. Our terpene mixing calculator can help develop proprietary terpene profiles tailored to specific product goals.
Sourcing Considerations: Identifying Quality Myrcene
For product developers, here are the technical indicators that help identify premium-quality terpene inputs:
Quality Indicators for Myrcene Sources
Extraction methodology significantly impacts final product quality. Steam distillation or subcritical CO₂ extraction preserves natural terpene ratios and prevents thermal degradation, resulting in higher monoterpene retention compared to solvent-based methods. Terpene Belt Farms utilizes advanced extraction techniques specifically optimized for terpene preservation.
Comprehensive analytical testing should include complete terpene profiling with chirality analysis, not just total myrcene content. Research suggests that enantiomeric ratios of terpenes can significantly impact sensory properties and physiological effects. As such, our testing protocol includes a detailed analysis of all terpene components to ensure complete profile characterization.
Moreover, documenting cultivation practices provides information on cannabis genetics, growing conditions, and harvest parameters. Harvest timing alone can alter myrcene concentrations, highlighting the importance of consistent agricultural practices. Our soil-to-oil documentation provides complete traceability for all terpene products.
Sensory evaluation by trained personnel should confirm complex, authentic cannabis aroma without metallic or chemical notes. Trained evaluators can reliably identify aroma defects that indicate quality issues such as oxidation or contamination. Our quality control processes include standardized sensory assessment for every production batch.
Proper storage is essential for terpene preservation. Nitrogen-flushed containers with refrigerated storage and temperature monitoring can extend terpene shelf life by up to 14 months compared to conventional packaging. That’s why our terpene products ship in nitrogen-flushed containers to maintain maximum freshness.
At Terpene Belt Farms, our Native Cannabis Terpenes undergo rigorous quality verification, including:
- Full-panel terpene analysis with detailed reporting of all detected compounds above 0.01%
- Batch-specific certificates of analysis documenting complete terpene profiles
- Terroir-specific sourcing from California’s premier cannabis growing regions
- Controlled cold-chain handling from harvest through extraction and shipping
- Stability-optimized packaging designed specifically for terpene preservation
A quality-focused approach ensures consistent, authentic myrcene profiles that deliver predictable outcomes for product developers. When selecting a terpene supplier, these scientific quality indicators should guide purchasing decisions beyond price considerations.
Conclusion: Strategic Implementation of Myrcene in Product Development
Myrcene is a cornerstone compound in cannabis product formulation. Research positions it as one of the most pharmacologically significant terpenes in cannabis. By understanding the technical aspects of myrcene integration, manufacturers can use it to create differentiated, effective products.
For premium brands prioritizing authentic cannabis experiences, sourcing decisions should focus on cannabis-derived myrcene with documentation of origin, extraction methodology, and comprehensive analytical testing.
Studies further show that full-spectrum cannabis extracts containing native terpene profiles produce more consistent effects than isolated compounds, supporting the value of authentic terpene profiles.
Therefore, whether developing relaxation-focused vapes, sleep-supporting edibles, or pain-relief topicals, myrcene’s unique properties offer product developers powerful tools for creating targeted consumer experiences with consistent, reliable outcomes.
By partnering with us, manufacturers gain access to California’s finest cannabis-derived terpenes, supported by extraction expertise and comprehensive documentation.
Shop Our FNF Terpenes and discover the difference authentic, California-grown cannabis terpenes can make in your product development process.
Frequently Asked Questions
What is Myrcene, and Why is it Significant in Cannabis Products?
Myrcene is a monoterpene hydrocarbon known for its earthy, musky aroma with subtle fruity and clove-like notes. It’s one of the most prevalent terpenes in cannabis and contributes significantly to the plant’s aroma and therapeutic effects. It plays a major role in formulations targeting relaxation, sleep, pain relief, and inflammation.
How Does Cannabis-Derived Myrcene Differ from Botanical or Synthetic Sources?
Cannabis-derived myrcene includes a complex blend of trace cannabinoids and synergistic terpenes not found in botanical or synthetic sources. These additional compounds enhance its sedative, analgesic, and aromatic effects.
What Quality Indicators Should Developers Look for When Sourcing Myrcene?
- Extracted using low-heat extraction methods like steam distillation or CO₂
- Full-spectrum terpene analysis and chirality testing
- Documentation on cannabis genetics and cultivation
- Cold-chain handling and nitrogen-flushed packaging.
- Pass sensory evaluation for aroma authenticity
Sources Used in Article:
Casano, S., Grassi, G., Martini, V., & Michelozzi, M. (2011). Variations In Terpene Profiles of Different Strains of Cannabis Sativa L. Acta Horticulturae, 925, 115–121. https://doi.org/10.17660/actahortic.2011.925.15
Chen, J., Jiang, Q.-D., Chai, Y.-P., Zhang, H., Peng, P., & Yang, X.-X. (2016). Natural terpenes as penetration enhancers for transdermal drug delivery. Molecules, 21(12), 1709. https://doi.org/10.3390/molecules21121709
Ferber, S. G., Namdar, D., Hen-Shoval, D., Eger, G., Koltai, H., Shoval, G., Shbiro, L., & Weller, A. (2020). The “entourage effect”: Terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders. Current Neuropharmacology, 18(2), 87–96. https://doi.org/10.2174/1570159×17666190903103923
Fischedick, J. T., Hazekamp, A., Erkelens, T., Choi, Y. H., & Verpoorte, R. (2010). Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry, 71(17–18), 2058–2073. https://doi.org/10.1016/j.phytochem.2010.10.001
Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., Xie, X.-Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008). Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences, 105(26), 9099–9104. https://doi.org/10.1073/pnas.0803601105
Gurgel do Vale, T., Couto Furtado, E., Santos, J. G., Jr., & Viana, G. S. B. (2002). Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba (Mill.) N.E. Brown. Phytomedicine, 9(8), 709–714. https://doi.org/10.1078/094471102321621304
Hanuš, L. O., & Hod, Y. (2020). Terpenes/Terpenoids in Cannabis: Are They Important? Medical Cannabis and Cannabinoids, 3(1), 25–60. https://doi.org/10.1159/000509733
Jansen, C., Shimoda, L. M. N., Kawakami, J. K., Ang, L., Bacani, A. J., Baker, J. D., Badowski, C., Speck, M., Stokes, A. J., Small-Howard, A. L., & Turner, H. (2019). Myrcene and terpene regulation of TRPV1. Channels, 13(1), 344–366. https://doi.org/10.1080/19336950.2019.1654347
Lasoń, E. (2020). Topical administration of terpenes encapsulated in nanostructured lipid-based systems. Molecules, 25(23), 5758. https://doi.org/10.3390/molecules25235758
Lim, S. S., Shin, K. H., Ban, H. S., Kim, Y. P., Jung, S. H., Kim, Y. J., & Ohuchi, K. (2002). Effect of the Essential Oil from the Flowers of Magnolia sieboldii on the Lipopolysaccharide-Induced Production of Nitric Oxide and Prostaglandin E2 by Rat Peritoneal Macrophages. Planta Medica, 68(5), 459–462. https://doi.org/10.1055/s-2002-32085
Maayah, Z. H., Takahara, S., Ferdaoussi, M., & Dyck, J. R. B. (2020). The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, 1866(7), 165771. https://doi.org/10.1016/j.bbadis.2020.165771
National Center for Biotechnology Information. (2025). PubChem Compound Summary for CID 31253, Myrcene. National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/Myrcene
Oswald, I. W. H., Paryani, T. R., Sosa, M. E., Ojeda, M. A., Altenbernd, M. R., Grandy, J. J., Shafer, N. S., Ngo, K., Peat, J. R., III, Melshenker, B. G., Skelly, I., Koby, K. A., Page, M. F. Z., & Martin, T. J. (2023). Minor, nonterpenoid volatile compounds drive the aroma differences of exotic cannabis. ACS Omega, 8(42), 39203–39216. https://doi.org/10.1021/acsomega.3c04496
Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46. https://doi.org/10.1089/can.2015.29003.ebr
Raeber, J., Bajor, B., Poetzsch, M., & Steuer, C. (2024). Comprehensive analysis of chemical and enantiomeric stability of terpenes in Cannabis sativa L. flowers. Phytochemical Analysis, 36(1), 205–217. https://doi.org/10.1002/pca.3432
Sousa, V. I., Parente, J. F., Marques, J. F., Forte, M. A., & Tavares, C. J. (2022). Microencapsulation of essential oils: A review. Polymers, 14(9), 1730. https://doi.org/10.3390/polym14091730
Vale, T. G., Furtado, E., Santos, J. G., & Viana, G. S. B. (2000). Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba (Mill.) N.E. Brown. Phytomedicine, 9, 709–714.
